When Can We Safely Stop Luteal Phase Support in Fresh IVF Cycles? A Literature Review

There is no consensus on the optimal duration of luteal phase support (LPS) in fresh IVF cycles. Although some clinicians withdraw LPS on the day of a positive pregnancy test, most clinicians continue its administration at least up to the 8th week of gestation. In this literature review, we included several randomized clinical trials comparing early and late cessation of LPS. Most studies have found no benefit in extended administration. These studies, however, were limited by their small sample size and selection bias. Until now, only a few attempts have been made to indicate when LPS can be safely stopped based on individual patient characteristics. In conclusion, the quality and quantity of the evidence regarding LPS duration in fresh IVF cycles is currently insufficient to justify early cessation in all patients. Individualization of LPS should receive high priority in future research.

[1]  S. Sunkara,et al.  ESHRE guideline: ovarian stimulation for IVF/ICSI† , 2020, Human reproduction open.

[2]  M. Depenbusch,et al.  Characterization of early pregnancy placental progesterone production by use of dydrogesterone in programmed frozen-thawed embryo transfer cycles. , 2020, Reproductive biomedicine online.

[3]  S. Nelson,et al.  Short versus extended progesterone supplementation for luteal phase support in fresh IVF cycles: a systematic review and meta-analysis. , 2019, Reproductive biomedicine online.

[4]  Shee-Uan Chen,et al.  Early stop of progesterone supplementation after confirmation of pregnancy in IVF/ICSI fresh embryo transfer cycles of poor responders does not affect pregnancy outcome , 2018, PloS one.

[5]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[6]  S. Kol,et al.  Luteal phase support post IVF: individualized early stop. , 2015, Reproductive biomedicine online.

[7]  C. Farquhar,et al.  Luteal phase support for assisted reproduction cycles. , 2015, The Cochrane database of systematic reviews.

[8]  Z. Alfirevic,et al.  Duration of luteal support after IVF is important, so why is there no consistency in practice? The results of a dynamic survey of practice in the United Kingdom , 2015, Human fertility.

[9]  K. V. Andersen,et al.  Improving the luteal phase after ovarian stimulation: reviewing new options , 2014 .

[10]  Z. Shoham,et al.  Luteal-phase support in assisted reproduction treatment: real-life practices reported worldwide by an updated website-based survey. , 2014, Reproductive biomedicine online.

[11]  H. Qi,et al.  The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis , 2012, Reproductive Biology and Endocrinology.

[12]  A. Pellicer,et al.  Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial. , 2012, Fertility and sterility.

[13]  Z. Alfirevic,et al.  Duration of luteal support (DOLS) with progesterone pessaries to improve the success rates in assisted conception: study protocol for a randomized controlled trial , 2012, Trials.

[14]  B. Tarlatzis,et al.  Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. , 2011, Human reproduction.

[15]  G. Griesinger Editorial commentary: is it time to abandon progesterone supplementation of early pregnancy after IVF? , 2011, Human reproduction.

[16]  T. Nagel,et al.  Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial. , 2010, Fertility and sterility.

[17]  S. Daya Luteal support: progestogens for pregnancy protection. , 2009, Maturitas.

[18]  G. Serour,et al.  Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks. , 2008, Human reproduction.

[19]  F. Schmidt Meta-Analysis , 2008 .

[20]  P. Devroey,et al.  An update of luteal phase support in stimulated IVF cycles. , 2007, Human reproduction update.

[21]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[22]  A. Loft,et al.  Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. , 2002, Human reproduction.

[23]  A. Loft,et al.  Progesterone supplementation during early gestation after in vitro fertilization has no effect on the delivery rate. , 2001, Fertility and sterility.

[24]  Z. Shoham,et al.  Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration. , 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[25]  Z. Shoham,et al.  Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation. , 1996, Human reproduction.

[26]  J. Collins,et al.  The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. , 1994, Fertility and sterility.

[27]  D. Krebs,et al.  The effect of 17α-hydroxyprogesterone caproate/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: A prospective and randomized controlled trail , 1992 .

[28]  Wei Huang,et al.  A meta-analysis of randomized trials , 2019 .

[29]  J. Mao,et al.  Local infiltration with cocktail analgesics during 2 level lumbar spinal fusion surgery , 2019, Medicine.